White Light Scanning to Aid Body Contouring: A Pilot Project

Status Recruiting

Clinical Trial Summary

A white light scanner can more accurately measure body contouring subjects than standard anthropomorphic methods.

Clinical Trial Description

A 3-D digital body camera that employs non-intrusive white light phase profilometry and 24 coordinated charge-coupled cameras scans and produces a "point cloud" image of the subject. The result of the two-minute scan process is an accurate three-dimensional body model of the subject, consisting of over 1.2 million surface points. The point cloud is compressed to provide programmable measurement extraction profiles (MEP's) that automatically extracts linear and circumferential measurements. Subjects are scanned and anthropometrically measured pre-operatively, and at 3, 6 and 9 months post-op. ;

Study Design

Observational Model: Case-Only, Time Perspective: Prospective

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT01093950
Study type	Observational
Source	Eastern Virginia Medical School
Contact	DAVID A GILBERT, MD
Phone	757-274-4000
Email	Dagilb3@msn.com
Status	Recruiting
Phase	N/A
Start date	January 2005
Completion date	October 2020

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05419037` - Natural History of Pregnancy and Pregnancy Outcomes in Metreleptin-Treated vs Untreated Subjects With Lipodystrophy
Recruiting	`NCT03059121` - The Cleveland Cardiometabolic Cohort
Completed	`NCT00656175` - Raltegravir Therapy for Women With HIV and Fat Accumulation	Phase 2
Completed	`NCT00202241` - The Effects of Anabolic Steroids and Protease Inhibitors on People Living With HIV/AIDS	N/A
Completed	`NCT00006185` - Underlying Abnormalities in Fat and Muscle Leading to Lipodystrophy Syndrome	Phase 1
Recruiting	`NCT02262832` - Compassionate Use of Metreleptin in Previously Treated People With Generalized Lipodystrophy	Phase 3
Completed	`NCT01679197` - Clinical Protocol to Investigate the Efficacy of Recombinant Human Leptin (Metreleptin) in Nonalcoholic Steatohepatitis (NASH) or Nonalcoholic Fatty Liver Disease (NAFLD) Associated With Lipodystrophy	Phase 2
Completed	`NCT02647853` - Phase 1 Study to Assess the Safety and Tolerability of TAT4 Gel in Healthy Volunteers	Phase 1
Active, not recruiting	`NCT00715546` - Autologous Adipose-Derived Stem Cell Transplantation in Patients With Lipodystrophy	Phase 1
Completed	`NCT00069004` - A Study of Physical and Metabolic Abnormalities in HIV Infected and Uninfected Children and Youth	N/A
Completed	`NCT00025883` - Leptin to Treat Lipodystrophy	Phase 2
Completed	`NCT00001142` - Metabolism and Body Shape of Healthy Children and Children With Chronic Infections	N/A
Active, not recruiting	`NCT02262806` - Compassionate Use of Metreleptin in Previously Treated People With Partial Lipodystrophy	Phase 2
Completed	`NCT02258685` - Factors Mediating Gut Microbiota Dysbiosis and Metabolic Disease in HIV Patients.
Completed	`NCT00192621` - Seronegatives and Metabolic Abnormalities Protocol 2 (SAMA002): Study to Compare the Effect of Kaletra and Combivir® in HIV-Negative Healthy Subjects	Phase 4
Completed	`NCT00006190` - A Study to Determine How and Why HIV-Infected Subjects on Anti-viral Treatment Develop Lipodystrophy	Phase 4
Recruiting	`NCT05930106` - Carotid Doppler Peak Velocity Variation in Liposuction Fluid Management	N/A
Completed	`NCT00004329` - Study of Alpha-2 Adrenergic Receptor Dysfunction in Regional Lipoatrophy	N/A
Recruiting	`NCT04656054` - Hemoglobin Level, Coagulopathy Profile and Electrolyte Balance
Completed	`NCT00082628` - Treatment of Abnormal Adipose Tissue Accumulation in Human Immunodeficiency Virus (HIV) Patients	Phase 3